The “large molecule dynamic” underpins Pall Corporation’s continued quarterly double-digit growth, says owner Danaher. Fellow bioprocessing vendor Sartorius also saw double-digit gains in sales revenue and earnings. “Pall had a great quarter, producing double-digit core revenue growth,” Tom Joyce, CEO of Pall’s parent company Danaher Corporation told stakeholders during its recent third quarter financial call. “In particular, our biotech business, including single-use technologies was up mid-teens in the quarter.” For Danaher’s total business, Q3 sales were $4.85 billion (€4.25 billion),…